Gene · 3812
Papers2,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 18 F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy. | Nucl Med Commun | 2023 | 37503694 | PubTator, text mining | PubMed |
| Sequence variants contributing to dysregulated inflammatory responses across keratoconic cone surface in adolescent patients with keratoconus. | Front Immunol | 2023 | 37483635 | PubTator, text mining | PubMed |
| Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients. | Sci Rep | 2023 | 37454198 | PubTator, text mining | PubMed |
| Aging modifies endometrial dendritic cell function and unconventional double negative T cells in the human genital mucosa. | Immun Ageing | 2023 | 37452337 | PubTator, text mining | PubMed |
| Advancing Cancer Research: Current Knowledge on Cutaneous Neoplasia. | Int J Mol Sci | 2023 | 37446352 | PubTator, text mining | PubMed |
| Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment. | Cells | 2023 | 37443742 | PubTator, text mining | PubMed |
| Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation? | Eur Respir Rev | 2023 | 37437915 | PubTator, text mining | PubMed |
| How molecular advances may improve the diagnosis and management of PTCL patients. | Front Oncol | 2023 | 37427095 | PubTator, text mining | PubMed |
| The genotype list string code syntax for exchanging nomenclature-level genotyping results in clinical and research data management and analysis systems. | HLA | 2023 | 37403548 | PubTator, text mining | PubMed |
| Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis. | EMBO J | 2023 | 37382276 | PubTator, text mining | PubMed |
| Combination Therapy as a Promising Way to Fight Oral Cancer. | Pharmaceutics | 2023 | 37376101 | PubTator, text mining | PubMed |
| Non-Classical HLA Class 1b and Hepatocellular Carcinoma. | Biomedicines | 2023 | 37371767 | PubTator, text mining | PubMed |
| Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population. | Innate Immun | 2023 | 37350049 | PubTator, text mining | PubMed |
| Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. | Cancers (Basel) | 2023 | 37345066 | PubTator, text mining | PubMed |
| A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G. | Front Immunol | 2023 | 37342325 | PubTator, text mining | PubMed |
| Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML). | BMC Immunol | 2023 | 37340345 | PubTator, text mining | PubMed |
| Exploration of KIR genes and hematological-related diseases in Chinese Han population. | Sci Rep | 2023 | 37328612 | PubTator, text mining | PubMed |
| Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires. | Blood Adv | 2023 | 37327114 | PubTator, text mining | PubMed |
| Negativity begets longevity in T cells. | J Clin Invest | 2023 | 37317967 | PubTator, text mining | PubMed |
| Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies. | Essays Biochem | 2023 | 37313600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3812/papers?page=9